Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan: TherapeuticsMD Inc (TXMD)

The current quotes for TherapeuticsMD, Inc. (TXMD) displayed on the GURU.Markets platform show an EV/EBITDA of 0.00. Sales stability is driven by female consumer loyalty to proven hormonal product lines. The company achieves broad audience reach by developing products for various life stages, including menopause. Financial stability is supported by a lack of debt, although revenue relies on licensing royalties and patent protection.

TXMD TherapeuticsMD: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ing interval 23.11.2025 - 14.11.2026

therapeuticsmd.com - rincian analitis lan metrik utama (TXMD)

- rega saham lan target rega konsensus:

Kutipan saham TherapeuticsMD|TXMD - Target konsensus

- indikator kapitalisasi bursa perusahaan:

Nilai pasar TXMD|TXMD - Total Nilai Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham TherapeuticsMD|TXMD - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku therapeuticsmd.com|TXMD - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas TherapeuticsMD, Inc.|TXMD - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas TherapeuticsMD|TXMD - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku TXMD|TXMD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TherapeuticsMD|Likuiditas cepet therapeuticsmd.com

- data bathi bisnis lan rasio investasi:

TXMD - Bathi pungkasan|Proyeksi bathi mangsa ngarep TherapeuticsMD, Inc.|TXMD - Pangali P/E|Rega marang bathi mangsa ngarep TherapeuticsMD|TXMD - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA TXMD|TXMD - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan TherapeuticsMD|TXMD - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan therapeuticsmd.com|TXMD - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep TherapeuticsMD, Inc.

- data dodolan lan asil:

TXMD - Pendapatan reged perusahaan|Prakiraan volume dodolan TherapeuticsMD|TXMD - Kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan TXMD

Analisis umum perusahaan:TherapeuticsMD Corp TXMD

The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit before depreciation, taxes, and interest, allowing for an asset valuation independent of capital structure. By analyzing the change in the EV/EBITDA value over time, a TherapeuticsMD, Inc. (TXMD) investor can determine a fair share price, given that the diversification of women's health medications and licensing contracts stabilize the company's cash flows.

Pesaing wigati

Organon Corp - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|DARE - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|PTN - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan